All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma

ConclusionAll-oral DEVEC showed an encouraging activity and acceptable toxicity. This schedule deserves further studies in elderly PTCL also for assessing combinations with targeted drugs.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research